Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil Once a Day Onset of Efficacy in ED
NCT00833638Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2009
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tadalafil in erectile dysfunction (ED) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Earliest Onset Day Measured by Cumulative Percentage of Participants With Yes Response to Sexual Encounter Profile Diary Question 3 at 4 days. Started Feb 2009; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00833638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833638.